Genetic variation at glucose and insulin trait loci and response to glucose-insulin-potassium (GIK) therapy: the IMMEDIATE trial

被引：6

作者：

Ellis, K. L. ^{[1
]}

Zhou, Y. ^{[2
]}

Beshansky, J. R. ^{[3
]}

Ainehsazan, E. ^{[1
]}

Yang, Y. ^{[1
]}

Selker, H. P. ^{[3
]}

Huggins, G. S. ^{[4
]}

Cupples, L. A. ^{[2
]}

Peter, I. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA

[2] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA

[3] Tufts Univ, Sch Med, Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA

[4] Tufts Med Ctr, Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA USA

来源：

PHARMACOGENOMICS JOURNAL | 2015年 / 15卷 / 01期

基金：

美国国家卫生研究院;

关键词：

GENOME-WIDE ASSOCIATION; ACUTE CORONARY SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES RISK; INTRAVENOUS GLUCOSE; SUSCEPTIBILITY LOCI; VARIANTS; METAANALYSIS; SEQUENCE; RELEASE;

D O I：

10.1038/tpj.2014.41

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The mechanistic effects of intravenous glucose, insulin and potassium (GIK) in cardiac ischemia are not well understood. We conducted a genetic sub-study of the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency care (IMMEDIATE) Trial to explore effects of common and rare glucose and insulin-related genetic loci on initial to 6-h and 6- to 12-h change in plasma glucose and potassium. We identified 27 NOTCH2/ADAM30 and 8 C2CD4B variants conferring a 40-57% increase in glucose during the first 6 h of infusion (P < 5.96 x 10(-6)). Significant associations were also found for ABCB11 and SLC30A8 single-nucleotide polymorphisms (SNPs) and glucose responses, and an SEC61A2 SNP with a potassium response to GIK. These studies identify genetic factors that may impact the metabolic response to GIK, which could influence treatment benefits in the setting of acute coronary syndromes (ACS).

引用

页码：55 / 62

页数：8

共 50 条

[21] MYOCARDIAL PRESERVATION WITH GLUCOSE-INSULIN-POTASSIUM (GIK) AND STEROIDS DURING ANOXIC ARREST
HICKS, GL
HILL, AA
DEWEESE, JA
SURGICAL FORUM, 1976, 27 : 239 - 241
[22] NITROGEN-BALANCE ACROSS HEART WITH INFUSION OF GLUCOSE-INSULIN-POTASSIUM (GIK)
MCDANIEL, HG
ROGERS, WJ
RUSSELL, RO
DIGERNESS, S
RACKLEY, CE
CLINICAL RESEARCH, 1978, 26 (03): : A484 - A484
[23] Glucose-Insulin-Potassium (GIK) for Acute Myocardial Infarction: A Negative Study with a Positive Value
Carl S. Apstein
Lionel H. Opie
Cardiovascular Drugs and Therapy, 1999, 13 : 185 - 189
[24] THE EFFECT OF GLUCOSE-INSULIN-POTASSIUM THERAPY ON REPERFUSION ARRHYTHMIAS
PUCKETT, SW
BOWDON, HR
RACKLEY, CE
CLINICAL RESEARCH, 1981, 29 (05): : A856 - A856
[25] THE EFFECT OF GLUCOSE-INSULIN-POTASSIUM THERAPY ON REPERFUSION ARRHYTHMIAS
PUCKETT, SW
BOWDON, H
RACKLEY, CE
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (04): : 1014 - 1014
[26] What About Beta-Blockers in the New Glucose-Insulin-Potassium (GIK) Era?
Jens Peder Bagger
Cardiovascular Drugs and Therapy, 2000, 14 : 347 - 348
[27] HEMODYNAMIC AND DIURETIC EFFECTS OF GIK (GLUCOSE-INSULIN-POTASSIUM) TREATMENT ON EXTENSIVE BURN PATIENTS
KOBAYASHI, H
YOSHIOKA, T
MAEMURA, K
OHASHI, N
SAWADA, Y
SUGIMOTO, T
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1983, 23 (02): : 116 - 122
[28] Glucose-insulin-potassium therapy in patients with STEMI -: Reply
Goyal, Abhinav
Diaz, Rafael
Mehta, Shamir R.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (20): : 2387 - 2388
[29] Glucose-insulin-potassium (GIK) for acute myocardial infarction: A negative study with a positive value
Apstein, CS
Opie, LH
CARDIOVASCULAR DRUGS AND THERAPY, 1999, 13 (03) : 185 - 189
[30] What about beta-blockers in the new glucose-insulin-potassium (GIK) era?
Bagger, JP
CARDIOVASCULAR DRUGS AND THERAPY, 2000, 14 (03) : 347 - 348

← 1 2 3 4 5 →